Pharmacological profile of LY301317, a potent and selective 5-HT(1A) agonist

Drug Development Research

Volumn 40, Issue 1, 1997, Pages 17-34

  Wolff, Mary C ^a   Benvenga, Mark J ^a   Calligaro, David O ^a   Fuller, Ray W ^a   Gidda, Jaswant S ^a   Hemrick Luecke, Susan ^a   Lucot, James B ^b   Nelson, David L ^a   Overshiner, Carl D ^a   Leander, J David ^a  

^a ELI LILLY AND COMPANY   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

5 HT(1A); Drug discrimination; Emesis; Forced swim; Punished responding

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CISPLATIN; HISTAMINE H1 RECEPTOR; IPECAC; RECEPTOR SUBTYPE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIEMETIC ACTIVITY; ARTICLE; BEHAVIOR; BINDING AFFINITY; BODY POSTURE; BRAIN TISSUE; CAT; CONFLICT; CONTROLLED STUDY; CORE TEMPERATURE; CORTICOSTERONE BLOOD LEVEL; DOG; DRUG RECEPTOR BINDING; MALE; MOTION SICKNESS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PIGEON; RAT; TRANQUILIZING ACTIVITY;

EID: 0031011681     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199701)40:1<17::AID-DDR2>3.0.CO;2-W     Document Type: Article

References (87)

1. 3 receptor antagonists: An overview of their present status and future potential in cancer therapy-induced emesis. Drugs 42:551-568.
2. Allen LE, Ferguson HC, Cox RH (1974): Pharmacological effects of M5 9022-1, a potential tranquillizing agent. Arzneimittel. Forschung (Drug Res) 24:917-921.
3. 1A) partial agonist in treatment of major depression. Prog Neuropsychopharmacol Biol Psychiatry 16:271-280.
4. Andrews PLR, Bhandari P (1993): The 5-hydroxytryptamine receptor antagonists as antiemetics: Preclinical evaluation and mechanisms of action. Eur J Cancer 29A:S11-S16.
5. Andrykowski M (1990): The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: A review and synthesis. Psychosom Med 52:458-475.
6. Azrin NH (1959): A technique for delivering shock to pigeons. J Exp Anal Behav 2:161-163.
7. 3 Antagonists and Benzodiazepines: Their Comparative Behavioral Pharmacology. New York: Wiley, pp 59-105.
8. 1A receptor antagonists BMY 7378 and NAN-190. Eur J Pharmacol 217:163-171.
9. 1A agonist, (+)S 20244 and its enantioners (+)S 20499 and (-)S 205000. Psychopharmacology 116:73-78.
10. Benvenga M, Leander JD (1993): Antidepressant-like effect of LY228729 as measured in the rodent forced swim paradigm. Eur J Pharmacol 239:249-252.
11. Benvenga MJ, Leander JD (1995): Olanzapine, an atypical antipsychotic, increases rates of punished responding in pigeons. Psychopharmacology 119:133-138.
12. 1A agnosis in pigeons are dependent on the level of response suppression. Behav Pharmacol 6:540-550.
13. 1A receptors induces lower lip retraction in the rat. Pharmacol Biochem Behav 33:821-827.
14. 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sci 35:1885-1893.
15. 3]idazoxan in rat brain. J Pharmacol Exp Ther 241:1092-1098.
16. 3]diazepam binding. Proc Natl Acad Sci USA 74:3805-3809.
17. Burish TG, Carey MP, Krozely MG, Greco FA (1987): Conditioned side effects induced by cancer chemotherapy: Prevention through behavioral treatment. J Consult Clin Psychol 55:42-18.
18. Bylund D, Snyder S (1976): Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol 12:568-580.
19. Charney DS, Woods SW, Krystal JH, Heninger GR (1990): Serotonin function and human anxiety disorders. Ann NY Acad Sci 600:558-573.
20. 50) of an enzymatic reaction. Biochem Pharmacol 22:3090-3108.
21. 3 receptor antagonist properties of ICS 205-930, GR38032F, and zacopride. J Pharmacol Exp Ther 248:197-201.
22. 1A agonist and potential anxiolytic agent. Drug Dev Res 26:21-48.
23. Crampton GH, Lucot JB (1985): A stimulator of laboratory studies of motion sickness in cats. Aviat Space Environ Med 56:462-465.
24. Crampton GH, Lucot JB (1991): Habituation of motion sickness in the cat. Aviat Space Environ Med 62:212-215.
25. Curzon G (1990): Serotonin and appetite. Ann NY Acad Sci 600:521-531.
26. 1A agonists in anxiety and depression. J Psychopharmocol 7:283-289.
27. 2 agonists. Br J Pharmacol 89:377-384.
28. 1A receptor agonists: Recent developments and controversial issues. Psychopharmacology 121:1-26.
29. Foreman MM, Fuller RW, Leander JD, Benvenga MJ, Wong DT, Nelson DL, Calligaro DO, Swanson SP, Lucot JB, Flaugh ME (1993): Preclinical studies on LY228729: A potent and selective serotonin1A agonist. J Pharmacol Exp Ther 267:58-71.
30. Foreman MM, Fuller RW, Rasmussen K, Nelson DL, Calligaro DO, Zhang L, Barrett JE, Booher RN, Paget CJ, Jr., Flaugh ME (1994): Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity. J Pharmacol Exp Ther 270:1270-1281.
31. Fuller RW (1996): Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats. Behav Brain Res 73:215-219.
32. Fuller RW, Perry KW (1989): Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats. J Pharmacol Exp Ther 248:50-56.
33. Fuller RW, Snoddy HD (1990): Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct-and indirect acting serotonin agonists. Neuroendocrinology 52:206-211.
34. Gilbert F, Stahl Sm, Tricklebank MD (1987): Characterization of the 5-HT receptor subtype mediating ACTH release in the rat. Br J Pharmacol 91:495P.
35. Glennon RA (1990): Serotonin receptors: Clinical implications. Neurosci Biobehav Rev 14:35-47.
36. 3H]prazosin to rat brain alpha adrenergic receptors. Eur J Pharmacol 55:323-328.
37. 1A receptor agonist, in treatment-resistant depression. Int Clin Psychopharmacol 8:67-172.
38. 2 receptors. Prog Neuro Psychopharmacol Biol Psychiatry 12:559-568.
39. Heller AH, Beneke M, Kuemmel B, Spencer D, Kurtz NM (1990): Ipsapirone: Evidence for efficacy in depression. Psychopharmacol Bull 26:219-222.
40. Hjorth S (1985): Hypothermia in the rat induced by the potent serotonergic agent, 8-OH-DPAT. J Neural Transm 62:131-135.
41. Hjorth S, Carlsson A (1982): Buspirone: Effects on central monoaminergic transmission - possible relevance to animal experimental and clinical findings. Eur J Pharmacol 83:299-303.
42. 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body autoreceptors in rat brain in vivo. Naunyn Schmeidbergs Arch Pharmacol 338:463-471.
43. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994): International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharm Rev 46:157-203.
44. Humphrey PP, Feniuk W, Perren MJ, Beresford IJ, Skingle M, Whalley ET (1990): Serotonin and migraine. Ann NY Acad Sci 600:587-600.
45. Jenkins S, Robinson D, Fabre LJ (1990): Gepirone in the treatment of major depression. J Clin Psychopharmacol 10(Suppl 3):77S-85S.
46. Jimerson DC, Lesern MD, Hegg AP, Brewerton TD (1990): Serotonin in human eating disorders. Ann NY Acad Sci 600:532-544.
47. 1A agonist 8-OH-DPAT: A study in the rat. Neuropharmacology 33:325-330.
48. Kamoto T, Ito H, Nagakura Y, Nishida A, Yuki H, Yamano M, Miyata K (1993): Mechanisms of cisplatin-and m-chlorophenylbiguanide-induced emesis in ferrets. Eur J Pharmacol 238:369-376.
49. King GL (1990): Animal studies in the study of vomiting. Can J Pharmacol 68:260-268.
50. 1A receptor-mediated effects of buspirone, gepirone, and ipsapirone. Pharmacol Biochem Behav 29:711-715.
51. 3 receptors prevents cisplatin-induced but not motion-or xylazine-induced emesis in the cat. Pharmacol Biochem Behav 32:207-210.
52. Lucot J (1994): Antiemetic effects of flesinoxin in cats: Comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin. Eur J Pharmacol 253:53-60.
53. Lucot J, Crampton G (1989): 8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin, or xylazine. Pharmacol Biochem Behav 33:627-631.
54. 1A receptor-mediated regulation of plasma neuroendocrine hormones. J Pharmacol Exp Ther 271:1246-1252.
55. 1A receptor-mediated regulation of plasma neuroendocrine hormones. Pharmacol Biochem Behav 43:405-411.
56. Meltzer HY (1990): Role of serotonin in depression. Ann NY Acad Sci 600:486-500.
57. 1 recognition site. Eur J Pharmacol 90:151-153.
58. Millan MJ, Rivet J-M, Canton H, Le Marouille-Girardon S, Gober A (1993): Induction of hypothermia as a model of 5-hydroxytryptamine receptor-mediated activity in the rat: A pharmacological characterization of the actions of novel agonists and antagonists. J Pharmacol Exp Ther 264:1364-1376.
59. 1A agonists and antagonists. Pharmacol Biochem Behav 46:141-143.
60. Munson PJ, Rodbard JD (1980): Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
61. 1A-receptor agonists in Suncus murinus. Jpn J Pharmacol 64:109-114.
62. 3 receptor antagonists for chemotherapy-induced emesis. J Clin Oncol 13:1036-1043.
63. Porsolt RD, LePichon MMJ (1977): Depression: A new animal model sensitive to antidepressant treatments. Nature 266:730.
64. Rickels K, Amsterdam JD, Clary C, Puzzuoli G, Schweizer E (1991): Buspirone in major depression: A controlled study. J Clin Psychiatry 52:34-38.
65. Rudd JA, Naylor RJ (1995): The effect of "broad spectrum" antiemetic drugs on nicotine-induced emesis in the Suncus murinus. Br J Pharmacol 114:385.
66. Rudd JR, Bunce KT, Naylor RJ (1992): The effect of 8-OH-DPAT on drug-induced emesis in the ferret. Br J Pharmacol 106:101.
67. Schipper J, Tulp M, Berkelmans B, Mos J, Van Der Heijden J, Olivier B (1991): Preclinical pharmacology of flesinoxan: A potential anxiolytic and antidepressant drug. Hum Psychopharmacol 6:S53-61.
68. 1A receptor ligands in animal models of anxiety, impulsivity and depression: Multiple mechanisms of action? Pro Neuro Psychopharmacol Biol Psychiatry 17:87-104.
69. 1A receptor agonists 8-OH-DPAT and ipsapirone in the rat forced swimming test. Behav Pharmacol 4:625-636.
70. 1A receptor agonist, 8-hydrox-2-(di-n-propylamino)tetralin. J Pharmacol Exp Ther 275:822-831.
71. Schwartz SM, Goldberg MJ, Gidda JS, Cerimele BJ (1994): Effect of zatosetron on Ipecac-induced emesis in dogs and healthy men. J Clin Pharmacol 34:250-254.
72. 1A receptor activation by flesinoxan in humans: Body temperature and neuroendocrine responses. Neuropsychopharmacology 13:93-104.
73. Simansky KJ (1996): Serotonergic control of the organization of feeding and satiety. Behav Brain Res 73:37-42.
74. 1A selective drugs on the 5-HT behavioral syndrome. Pharmacol Biochem Behav 24:1513-1519.
75. Solem JH, Brink-Johnsen (1965): An evaluation of a method for determination of free corticosteroids in minute quantities of mouse plasma. Scand J Clin Invest 17(Suppl 80):1-14.
76. 1B agonists. Synapse 1:3-9.
77. Taylor DP (1990): Serotonergic agents in anxiety. Ann NY Acad Sci 600:545-557.
78. 1A binding site. J Pharmacol Exp Ther 236:118.
79. 3]mepyramine. Proc Natl Acad Sci USA 75:6290-6294.
80. 1A agonists measured with the forced swim assay. Psychopharmacology 101:497-504.
81. 3]muscimol, a potent gamma aminobutyric acid agonist, to rat brain synaptosomal membranes using liltration assay. J Neurochem 32:713-718.
82. Willner P (1984): The validity of animal models of depression. Psychopharmacology 83:1-16.
83. 1A agonists in the pigeon. Pharmacol Biochem Beh 49:385-391.
84. 3 antagonists in the pigeon. Pharmacol Biochem Behav 52:571-575.
85. 1A selective compounds with mixed agonist/antagonist properties. Soc Neurosci Abst 22:1586.
86. 1D subtypes. Life Sci 45:1433-1442.
87. Yamamura H, Snyder S (1974): Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA 71:1725-1729.